News

World's first primary standard developed for molecular radiotherapy

The new primary standard for MRT
The new primary standard for MRT

Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer

The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.

Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard.  A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.

Select your area of interest
World Metrology Day 2020
2020-05-20

On May the 20th this year we celebrate World Metrology Day marking 145 years of international cooperation in Metrology. more

EURAMET research improves drug infusion for intensive care patients
2020-05-20

EMPIR project inspires positive changes to the care of patients in intensive care more

Online Workshop for Multiphase Reference Metrology
2020-05-18

Thursday 4 June 2020, 09:30 to 11:30 UK time more

EURAMET research leads to continuing improvements for intravenous drug delivery
2020-05-15

EMPIR project strives to improve the accuracy of intravenous drug delivery more

Page 1 of 155.